We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
-1.96%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
AUM
$630M
AUM Growth
-$3.2M
Cap. Flow
+$12.6M
Cap. Flow %
2%
Top 10 Hldgs %
12.02%
Holding
658
New
212
Increased
94
Reduced
94
Closed
258

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$9.93M
2
V icon
Visa
V
+$8.94M
3
NKE icon
Nike
NKE
+$8.45M
4
UNP icon
Union Pacific
UNP
+$7.26M
5
DT icon
Dynatrace
DT
+$6.99M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$8.47M
2
ULTA icon
Ulta Beauty
ULTA
+$7.49M
3
WMT icon
Walmart Inc
WMT
+$7.46M
4
CTAS icon
Cintas
CTAS
+$7.26M
5
LULU icon
lululemon athletica
LULU
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Consumer Discretionary 15.22%
3 Healthcare 14.38%
4 Industrials 14.31%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PII icon
351
Polaris
PII
$4.19B
$318K 0.05%
+4,061
New +$344K
CACI icon
352
CACI
CACI
$10.3B
$316K 0.05%
+734
New +$300K
RARE icon
353
Ultragenyx Pharmaceutical
RARE
$2.73B
$315K 0.05%
+7,671
New +$328K
MMM icon
354
3M
MMM
$89.3B
$315K 0.05%
3,082
-6,680
-68% -$651K
STEP icon
355
StepStone Group
STEP
$3.37B
$314K 0.05%
+6,841
New +$269K
HEI icon
356
HEICO Corp
HEI
$47.3B
$313K 0.05%
+1,400
New +$296K
CF icon
357
CF Industries
CF
$19.5B
$306K 0.05%
+4,124
New +$320K
WAT icon
358
Waters Corp
WAT
$36.5B
$302K 0.05%
+1,042
New +$333K
IONS icon
359
Ionis Pharmaceuticals
IONS
$8.77B
$295K 0.05%
6,187
-19,772
-76% -$811K
NYT icon
360
New York Times
NYT
$11.8B
$287K 0.05%
5,606
-3,978
-42% -$187K
GRAB icon
361
Grab
GRAB
$14B
$286K 0.05%
80,627
-11,173
-12% -$39.2K
T icon
362
AT&T
T
$159B
$285K 0.05%
+14,911
New +$259K
CMS icon
363
CMS Energy
CMS
$22.7B
$280K 0.04%
+4,709
New +$285K
UNF icon
364
Unifirst Corp
UNF
$5.22B
$280K 0.04%
+1,632
New +$263K
ITCI
365
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$277K 0.04%
4,047
-4,042
-50% -$280K
CYTK icon
366
Cytokinetics
CYTK
$11.4B
$262K 0.04%
+4,839
New +$292K
TNET icon
367
TriNet
TNET
$2.73B
$259K 0.04%
+2,585
New +$288K
MKSI icon
368
MKS Inc
MKSI
$23.5B
$258K 0.04%
+1,977
New +$249K
ALLY icon
369
Ally Financial
ALLY
$13.7B
$255K 0.04%
+6,432
New +$251K
CTRE icon
370
CareTrust REIT
CTRE
$10.1B
$254K 0.04%
+10,117
New +$251K
JCI icon
371
Johnson Controls International
JCI
$87.3B
$252K 0.04%
+3,793
New +$255K
CNO icon
372
CNO Financial Group
CNO
$4.92B
$247K 0.04%
8,913
-14,636
-62% -$399K
TNL icon
373
Travel + Leisure Co
TNL
$4.73B
$246K 0.04%
+5,462
New +$245K
NRG icon
374
NRG Energy
NRG
$28.9B
$242K 0.04%
3,114
-3,575
-53% -$277K
FIS icon
375
Fidelity National Information Services
FIS
$21B
$241K 0.04%
+3,199
New +$237K

Similar funds

Pearl River Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Pearl River Capital held 658 positions worth $630M, down 0.51% from $633M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Pearl River Capital's Q2 2024 filing shows 212 new, 94 increased, 94 reduced and 258 closed positions. Its largest new stake was Medtronic: 121,092 shares worth $9.53M. The largest sale was Home Depot, an estimated $8.47M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Pearl River Capital's largest Q2 2024 buy was Medtronic: 121,092 shares worth $9.53M.
  • Pearl River Capital added most to Visa in Q2 2024, an estimated $8.94M increase.
  • Pearl River Capital's biggest Q2 2024 reduction was Marathon Petroleum, cutting an estimated $5.62M.
  • Pearl River Capital fully exited Home Depot in Q2 2024, selling an estimated $8.47M.
  • Pearl River Capital's ten largest holdings make up 12% of its $630M portfolio in Q2 2024.
  • Pearl River Capital opened 212 new positions and closed 258 in Q2 2024.
  • Pearl River Capital's portfolio value fell 0.51% quarter-over-quarter to $630M.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.